FdaApplication

ANDA 207495

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAMNEAL PHARMACEUTICALS OF NEW YORK LLC
application_typeANDA
approval_date2019-02-08

Products (2)

ProductActive ingredientStrengthDosage form
IMATINIB MESYLATEIMATINIB MESYLATEEQ 400MG BASETABLET;ORAL
IMATINIB MESYLATEIMATINIB MESYLATEEQ 100MG BASETABLET;ORAL

2 products